AIP
PASG icon

Ameritas Investment Partners’s Passage Bio PASG Stock Holding History

Ameritas Investment Partners’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-145
Closed -$9K – 3191
2022
Q1 		$9K Hold
145
– – ﹤0.01% 2830
2021
Q4 		$18K Hold
145
– – ﹤0.01% 2690
2021
Q3 		$29K Hold
145
– – ﹤0.01% 2495
2021
Q2 		$39K Buy
145
+41
+39% +$12.7K ﹤0.01% 2350
2021
Q1 		$36K Hold
104
– – ﹤0.01% 2277
2020
Q4 		$53K Buy
104
+44
+73% +$17.6K ﹤0.01% 1958
2020
Q3 		$16K Hold
60
– – ﹤0.01% 2495
2020
Q2 		$33K Buy
+60
New +$27K ﹤0.01% 2083

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's PASG Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 145 shares — an estimated $9K sold.

Ameritas Investment Partners first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $53K in Q4 2020. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 145 Passage Bio shares in Q2 2022, an estimated $9K.
  • Ameritas Investment Partners first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's Passage Bio position peaked at $53K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.